Opinion: China Technology Bills Need Targeted, Verifiable Risk Standards
Rep. Sheri Biggs introduced three measures focused on cellular modules, advanced robotics and biotechnology linked to China's military-civil technology strategy.
Defense systems should exclude components with documented control, cyber or supply-chain risks, but restrictions should use clear ownership and technical criteria so procurement decisions remain enforceable and do not sweep in low-risk products without evidence.
What the release says
Biggs announced three separate bills addressing cellular modules, advanced robotics and biotechnology used in defense-related supply chains.
The release says the measures build on amendments previously offered for the fiscal 2027 defense authorization bill and on a Senate cellular-module proposal.
The office describes the bills as tools to identify and mitigate technology risks associated with China's military-civil fusion strategy.
The measures are proposals and have not been enacted; the release does not provide a full section-by-section description of all three bills.
Read the official release: Congresswoman Sheri Biggs Fights to Keep Chinese Technology out of America's Defense SystemsOur centrist perspective
The practical effect will depend on how the bills define covered entities, control, component origin, mitigation and agency review.
Risk-based procurement rules can strengthen defense security while allowing trusted domestic and allied suppliers to compete.
The tradeoffs
Tighter screening can reduce espionage, disruption and dependence risks, while overly broad restrictions may raise costs or cut off components before alternatives are available.
Sector-wide concern is not a substitute for supplier-level evidence, technical testing and a process for correcting inaccurate designations.
What to watch next
- Watch for public bill text, committee referrals, covered-entity definitions and implementation deadlines.
- Watch whether agencies receive resources for technical review and whether restrictions coordinate with allies and existing procurement rules.
This is an editorial interpretation, not an official agency statement. Factual summaries rely on the linked release; implications and recommendations are our opinion. How we work
